2v2w: Difference between revisions

No edit summary
No edit summary
Line 7: Line 7:
|ACTIVITY=  
|ACTIVITY=  
|GENE=  
|GENE=  
|DOMAIN=
|RELATEDENTRY=[[1akj|1AKJ]], [[1ao7|1AO7]], [[1aqd|1AQD]], [[1b0g|1B0G]], [[1b0r|1B0R]], [[1bd2|1BD2]], [[1duy|1DUY]], [[1duz|1DUZ]], [[1eey|1EEY]], [[1eez|1EEZ]], [[1hhg|1HHG]], [[1hhh|1HHH]], [[1hhi|1HHI]], [[1hhj|1HHJ]], [[1hhk|1HHK]], [[1hla|1HLA]], [[1i1f|1I1F]], [[1i1y|1I1Y]], [[1i4f|1I4F]], [[1i7r|1I7R]], [[1i7t|1I7T]], [[1i7u|1I7U]], [[1im3|1IM3]], [[1jf1|1JF1]], [[1jht|1JHT]], [[1lp9|1LP9]], [[1oga|1OGA]], [[1p7q|1P7Q]], [[1qew|1QEW]], [[1qr1|1QR1]], [[1qrn|1QRN]], [[1qse|1QSE]], [[1qsf|1QSF]], [[1s8d|1S8D]], [[1s9w|1S9W]], [[1s9x|1S9X]], [[1s9y|1S9Y]], [[1t1w|1T1W]], [[1t1x|1T1X]], [[1t1y|1T1Y]], [[1t1z|1T1Z]], [[1t20|1T20]], [[1t21|1T21]], [[1t22|1T22]], [[1tvb|1TVB]], [[1tvh|1TVH]], [[1ur7|1UR7]], [[2av1|2AV1]], [[2av7|2AV7]], [[2bnq|2BNQ]], [[2bnr|2BNR]], [[2bsu|2BSU]], [[2bsv|2BSV]], [[2c7u|2C7U]], [[2clr|2CLR]], [[2gj6|2GJ6]], [[2jcc|2JCC]], [[2uwe|2UWE]], [[3hla|3HLA]], [[1a1m|1A1M]], [[1a1n|1A1N]], [[1a1o|1A1O]], [[1a6z|1A6Z]], [[1a9b|1A9B]], [[1a9e|1A9E]], [[1agb|1AGB]], [[1agc|1AGC]], [[1agd|1AGD]], [[1age|1AGE]], [[1agf|1AGF]], [[1c16|1C16]], [[1ce6|1CE6]], [[1cg9|1CG9]], [[1de4|1DE4]], [[1e27|1E27]], [[1e28|1E28]], [[1efx|1EFX]], [[1exu|1EXU]], [[1gzp|1GZP]], [[1gzq|1GZQ]], [[1hsa|1HSA]], [[1hsb|1HSB]], [[1im9|1IM9]], [[1jgd|1JGD]], [[1jge|1JGE]], [[1jnj|1JNJ]], [[1k5n|1K5N]], [[1kpr|1KPR]], [[1ktl|1KTL]], [[1lds|1LDS]], [[1m05|1M05]], [[1m6o|1M6O]], [[1mhe|1MHE]], [[1mi5|1MI5]], [[1n2r|1N2R]], [[1of2|1OF2]], [[1ogt|1OGT]], [[1onq|1ONQ]], [[1py4|1PY4]], [[1q94|1Q94]], [[1qlf|1QLF]], [[1qqd|1QQD]], [[1qvo|1QVO]], [[1r3h|1R3H]], [[1sys|1SYS]], [[1syv|1SYV]], [[1tmc|1TMC]], [[1uqs|1UQS]], [[1uxs|1UXS]], [[1uxw|1UXW]], [[1vgk|1VGK]], [[1w0v|1W0V]], [[1w0w|1W0W]], [[1w72|1W72]], [[1x7q|1X7Q]], [[1xh3|1XH3]], [[1xr8|1XR8]], [[1xr9|1XR9]], [[1xz0|1XZ0]], [[1ydp|1YDP]], [[1ypz|1YPZ]], [[1zs8|1ZS8]], [[1zsd|1ZSD]], [[1zt4|1ZT4]], [[2a83|2A83]], [[2ak4|2AK4]], [[2axf|2AXF]], [[2axg|2AXG]], [[2bck|2BCK]], [[2bsr|2BSR]], [[2bss|2BSS]], [[2bst|2BST]], [[2bvq|2BVQ]], [[2cii|2CII]], [[2cik|2CIK]], [[2d31|2D31]], [[2esv|2ESV]], [[2f74|2F74]], [[2f8o|2F8O]], [[2h26|2H26]], [[2hjk|2HJK]], [[2hjl|2HJL]], [[2hla|2HLA]], [[2v2x|2V2X]]
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2v2w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2v2w OCA], [http://www.ebi.ac.uk/pdbsum/2v2w PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2v2w RCSB]</span>
}}
}}


Line 14: Line 17:
==Overview==
==Overview==
All thymically selected T cells are inherently cross-reactive, yet many data indicate a fine specificity in antigen recognition, which enables virus escape from immune control by mutation in infections such as the human immunodeficiency virus (HIV). To address this paradox, we analyzed the fine specificity of T cells recognizing a human histocompatibility leukocyte antigen (HLA)-A2-restricted, strongly immunodominant, HIV gag epitope (SLFNTVATL). The majority of 171 variant peptides tested bound HLA-A2, but only one third were recognized. Surprisingly, one recognized variant (SLYNTVATL) showed marked differences in structure when bound to HLA-A2. T cell receptor (TCR) recognition of variants of these two peptides implied that they adopted the same conformation in the TCR-peptide-major histocompatibility complex (MHC) complex. However, the on-rate kinetics of TCR binding were identical, implying that conformational changes at the TCR-peptide-MHC binding interface occur after an initial permissive antigen contact. These findings have implications for the rational design of vaccines targeting viruses with unstable genomes.
All thymically selected T cells are inherently cross-reactive, yet many data indicate a fine specificity in antigen recognition, which enables virus escape from immune control by mutation in infections such as the human immunodeficiency virus (HIV). To address this paradox, we analyzed the fine specificity of T cells recognizing a human histocompatibility leukocyte antigen (HLA)-A2-restricted, strongly immunodominant, HIV gag epitope (SLFNTVATL). The majority of 171 variant peptides tested bound HLA-A2, but only one third were recognized. Surprisingly, one recognized variant (SLYNTVATL) showed marked differences in structure when bound to HLA-A2. T cell receptor (TCR) recognition of variants of these two peptides implied that they adopted the same conformation in the TCR-peptide-major histocompatibility complex (MHC) complex. However, the on-rate kinetics of TCR binding were identical, implying that conformational changes at the TCR-peptide-MHC binding interface occur after an initial permissive antigen contact. These findings have implications for the rational design of vaccines targeting viruses with unstable genomes.
==Disease==
Known diseases associated with this structure: Abacavir hypersensitivity, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142800 142800]], Ankylosing spondylitis, susceptibility to, 1 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142800 142800]], Hypoproteinemia, hypercatabolic OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=109700 109700]], Stevens-Johnson syndrome, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142800 142800]]


==About this Structure==
==About this Structure==
Line 55: Line 55:
[[Category: ubl conjugation]]
[[Category: ubl conjugation]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 18:42:45 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 05:07:55 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA